18 U.S. Code § 3621. Imprisonment of a convicted person
(1) by redesignating subsection (g) as subsection (i); and
(2) by inserting after subsection (f) the following:
(g) Partnerships To Expand Access to Reentry Programs Proven To Reduce Recidivism.—
(1) Definition.—The term “demonstrated to reduce recidivism” means that the Director of Bureau of Prisons has determined that appropriate research has been conducted and has validated the effectiveness of the type of program on recidivism.
(2) Eligibility for recidivism reduction partnership.—A faith-based or community-based nonprofit organization that provides mentoring or other programs that have been demonstrated to reduce recidivism is eligible to enter into a recidivism reduction partnership with a prison or community-based facility operated by the Bureau of Prisons.
(3) Recidivism reduction partnerships.—The Director of the Bureau of Prisons shall develop policies to require wardens of prisons and community-based facilities to enter into recidivism reduction partnerships with faith-based and community-based nonprofit organizations that are willing to provide, on a volunteer basis, programs described in paragraph (2).
(4) Reporting requirement.—The Director of the Bureau of Prisons shall submit to Congress an annual report on the last day of each fiscal year that—
(A) details, for each prison and community-based facility for the fiscal year just ended—
(i) the number of recidivism reduction partnerships under this section that were in effect;
(ii) the number of volunteers that provided recidivism reduction programming; and
(iii) the number of recidivism reduction programming hours provided; and
(B) explains any disparities between facilities in the numbers reported under subparagraph (A).
The effective date of this subsection, referred to in subsec. (h)(1)(A), probably means the date of enactment of Pub. L. 115–391, which added subsec. (h) of this section and was approved Dec. 21, 2018.
The date of enactment of this subsection, referred to in subsec. (h)(4), is the date of enactment of Pub. L. 115–391, which was approved Dec. 21, 2018.
2018—Subsec. (b). Pub. L. 115–391, § 601, substituted in introductory provisions “shall designate the place of the prisoner’s imprisonment, and shall, subject to bed availability, the prisoner’s security designation, the prisoner’s programmatic needs, the prisoner’s mental and medical health needs, any request made by the prisoner related to faith-based needs, recommendations of the sentencing court, and other security concerns of the Bureau of Prisons, place the prisoner in a facility as close as practicable to the prisoner’s primary residence, and to the extent practicable, in a facility within 500 driving miles of that residence. The Bureau shall, subject to consideration of the factors described in the preceding sentence and the prisoner’s preference for staying at his or her current facility or being transferred, transfer prisoners to facilities that are closer to the prisoner’s primary residence even if the prisoner is already in a facility within 500 driving miles of that residence.” for “shall designate the place of the prisoner’s imprisonment.” and inserted at end of concluding provisions “Notwithstanding any other provision of law, a designation of a place of imprisonment under this subsection is not reviewable by any court.”
Subsec. (g). Pub. L. 115–391, § 504(f)(1), added subsec. (g) and redesignated former subsec. (g) as (i).
Subsec. (h). Pub. L. 115–391, § 102(a), added subsec. (h).
Subsec. (i). Pub. L. 115–391, § 504(f)(1)(A), redesignated subsec. (g) as (i).
2008—Subsec. (b). Pub. L. 110–199, § 251(b), inserted “Any order, recommendation, or request by a sentencing court that a convicted person serve a term of imprisonment in a community corrections facility shall have no binding effect on the authority of the Bureau under this section to determine or change the place of imprisonment of that person.” at end of concluding provisions.
Subsec. (e)(5)(A). Pub. L. 110–199, § 252, substituted “means a course of individual and group activities and treatment, lasting at least 6 months, in residential treatment facilities set apart from the general prison population (which may include the use of pharmocotherapies, where appropriate, that may extend beyond the 6-month period);” for “means a course of individual and group activities, lasting between 6 and 12 months, in residential treatment facilities set apart from the general prison population—
“(i) directed at the substance abuse problems of the prisoner;
“(iii) which may include the use of pharmacoptherapies, if appropriate, that may extend beyond the treatment period;”.
Subsec. (g). Pub. L. 110–199, § 231(f), added subsec. (g).
2006—Subsec. (e)(4). Pub. L. 109–162, § 1146(1), added par. (4) and struck out heading and text of former par. (4). Text read as follows: “There are authorized to be appropriated to carry out this subsection—
“(A) $13,500,000 for fiscal year 1996;
“(B) $18,900,000 for fiscal year 1997;
“(C) $25,200,000 for fiscal year 1998;
“(D) $27,000,000 for fiscal year 1999; and
“(E) $27,900,000 for fiscal year 2000.”
Subsec. (e)(5)(A)(iii). Pub. L. 109–162, § 1146(2), added cl. (iii).
Subsec. (f). Pub. L. 109–248 added subsec. (f).
1994—Subsec. (b). Pub. L. 103–322, § 32001(1), struck out “, to the extent practicable,” after “The Bureau shall” in concluding provisions.
Pub. L. 103–322, § 20401, inserted “In designating the place of imprisonment or making transfers under this subsection, there shall be no favoritism given to prisoners of high social or economic status.” after subsec. (b)(5).
Subsec. (e). Pub. L. 103–322, § 32001(2), added subsec. (e).
1990—Subsec. (b). Pub. L. 101–647 inserted at end “The Bureau shall, to the extent practicable, make available appropriate substance abuse treatment for each prisoner the Bureau determines has a treatable condition of substance addiction or abuse.”
Section effective Nov. 1, 1987, and applicable only to offenses committed after the taking effect of this section, see section 235(a)(1) of Pub. L. 98–473, set out as a note under section 3551 of this title.
 So in original. Probably should be “pharmacotherapies,”.